EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2

Sophie Broadway-Stringer, He Jiang, Kirsty Wadmore, Charlotte Hooper, Gillian Douglas iD, Violetta Steeples, Amar J Azad iD, Evie Singer, Jasmeet S Reyat iD, Frantisek Galatik iD, Elisabeth Ehler iD, Pauline Bennett und 7 weitere

Cells · 24.02.2023 · 12 (5) · 721

DOI: 10.3390/cells12050721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 24.02.2023. Verfasst von Sophie Broadway-Stringer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Cardiomyopathies, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants in ACTN2, coding for alpha-actinin 2, are known to be rare causes of Hypertrophic Cardiomyopathy. However, little is known about the underlying disease mechanisms. Adult heterozygous mice carrying the Actn2 p.Met228Thr variant were phenotyped by echocardiography. For homozygous mice, viable E15.5 embryonic hearts were analysed by High Resolution Episcopic Microscopy and wholemount staining, complemented by unbiased proteomics, qPCR and Western blotting. Heterozygous Actn2 p.Met228Thr mice have no overt phenotype. Only mature males show molecular parameters indicative of cardiomyopathy. By contrast, the variant is embryonically lethal in the homozygous setting and E15.5 hearts show multiple morphological abnormalities. Molecular analyses, including unbiased proteomics, identified quantitative abnormalities in sarcomeric parameters, cell-cycle defects and mitochondrial dysfunction. The mutant alpha-actinin protein is found to be destabilised, associated with increased activity of the ubiquitin-proteasomal system. This missense variant in alpha-actinin renders the protein less stable. In response, the ubiquitin-proteasomal system is activated; a mechanism that has been implicated in cardiomyopathies previously. In parallel, a lack of functional alpha-actinin is thought to cause energetic defects through mitochondrial dysfunction. This seems, together with cell-cycle defects, the likely cause of the death of the embryos. The defects also have wide-ranging morphological consequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesCardiomyopathy, HypertrophicAnimalsMaleMiceActininHeartUbiquitins

Stichwörter der Autor:innen

alpha-actinincardiomyopathyembryonic heartmitochondriaproteomicssarcomere

Substanzen

ActininUbiquitinsActn2 protein, mouse

Autor:innen und Institutionen

  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK.
  • Department of Physiology, Faculty of Science, Charles University, 12800 Prague, Czech Republic.
  • Randall Centre for Cell and Molecular Biophysics, King's College London, London SE1 9RT, UK.
  • School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence, King's College London, London SE1 9RT, UK.
  • Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK.

ORCID-Profile: Gillian Douglas, Amar J Azad, Jasmeet S Reyat, Frantisek Galatik, Elisabeth Ehler, Duncan B Sparrow, Kristina Djinovic-Carugo, Katja Gehmlich

Förderung

  • British Heart Foundation
  • Medical Research Council
  • Wellcome Trust
  • Oxford BHF Centre of Research Excellence
  • John Fell Oxford University Press Research Fund
  • UKRI-Medical Research Council

Zitieren

APA

Broadway-Stringer, S., Jiang, H., Wadmore, K., Hooper, C., Douglas, G., Steeples, V., Azad, A. J., Singer, E., Reyat, J. S., Galatik, F., Ehler, E., Bennett, P., Kalisch-Smith, J. I., Sparrow, D. B., Davies, B., Djinovic-Carugo, K., Gautel, M., Watkins, H., & Gehmlich, K. (2023). Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. Cells, 12(5), 721. https://doi.org/10.3390/cells12050721

Vancouver

Broadway-Stringer S, Jiang H, Wadmore K, Hooper C, Douglas G, Steeples V, et al. Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. Cells. 2023;12(5):721. doi:10.3390/cells12050721

BibTeX
@article{BroadwayStringer2023,
  author = {Broadway-Stringer, Sophie and Jiang, He and Wadmore, Kirsty and Hooper, Charlotte and Douglas, Gillian and Steeples, Violetta and Azad, Amar J and Singer, Evie and Reyat, Jasmeet S and Galatik, Frantisek and Ehler, Elisabeth and Bennett, Pauline and Kalisch-Smith, Jacinta I and Sparrow, Duncan B and Davies, Benjamin and Djinovic-Carugo, Kristina and Gautel, Mathias and Watkins, Hugh and Gehmlich, Katja},
  title = {Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {5},
  pages = {721},
  doi = {10.3390/cells12050721}
}
Kostenlos starten →